Consultation meeting on the development of therapeutic vaccines for post kala azar dermal leishmaniasis

BACKGROUND: Post kala azar dermal leishmaniasis (PKDL) is a disease that appears after treatment of visceral leishmaniasis (VL). The highest incidence of PKDL in the world is in Sudan. Many patients heal spontaneously within 6 months but those who don't are difficult to treat, often requiring m...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghalib, Hashim, Modabber, Farrokh
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2000869/
https://www.ncbi.nlm.nih.gov/pubmed/17705861
http://dx.doi.org/10.1186/1475-9292-6-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2000869/
https://www.ncbi.nlm.nih.gov/pubmed/17705861
http://dx.doi.org/10.1186/1475-9292-6-7

Ejemplares similares